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Abstract
Autologous bone grafts are widely used in oral and maxillofacial surgery, orthopedics, and traumatology. Autologous bone grafts not only
replace missing bone, they also support the complex process of bone regeneration. This favorable behavior of autografts is attributed to the
three characteristics: osteoconductivity, osteogenicity, and osteoinductivity. However, there is another aspect: Bone grafts release a myriad of
molecules, including growth factors, which can target mesenchymal cells involved in bone regeneration. The paracrine properties of bone grafts
can be studied in vitro by the use of bone-conditioned medium (BCM). Here we present a protocol on how to prepare bone-conditioned medium
from native pig cortical bone, and bone that underwent thermal processing or demineralization. Cells can be directly exposed to BCM or seeded
onto biomaterials, such as collagen membranes, previously soaked with BCM. We give examples for in vitro bioassays with mesenchymal cells
on the expression of TGF-β regulated genes. The presented protocols should encourage to further reveal the paracrine effects of bone grafts
during bone regeneration and open a path for translational research in the broad field of reconstructive surgery.
Video Link
The video component of this article can be found at http://www.jove.com/video/52707/
Introduction
Autologous bone is widely used to bridge defects that occurred as a consequence of malformation, resective surgery, reconstructive trauma
surgery, and prior to implant placement 1,2. Understanding the biological principles of how bone grafts support the process of graft consolidation
is not only key to understand why autografts are considered to be the gold standard in reconstructive surgery, it is also bionic to the improved
design of bone substitutes 3. Still, graft consolidation is faster with autologous bone compared to bone substitutes 4,5. Thus, it is imperative to
reveal the molecular and cellular mechanisms that make autologous bone so effective to support bone regeneration.
There are three textbook characteristics of autografts that are considered to support the consolidation process 6,7. First, autologous bone is
osteoconductive, providing guidance for the newly formed bone to grow into the defect. Secondly, autologous bone is osteogenic, meaning
that it contains mesenchymal cells that can differentiate into osteoblasts 8. Third, autologous bone is osteoinductive as growth factors like bone
morphogenetic proteins entombed in the matrix can initiate the process of endochondral or even intramembranous bone formation 9. There is
another aspect: freshly prepared bone chips hold a paracrine function based on the in vitro observations with “bone-conditioned medium” 10-15.
Also the impact of myelopoiesis should be mentioned 16. A similar term “demineralized bone matrix-conditioned medium” was already coined
in 1996 and supports the overall concept of a paracrine function of bone, even when processed by demineralization 17. For our purposes, BCM
can be prepared from fresh pig mandibles 10,11. Proteomic analyses of BCM revealed the complex composition, including growth factors and
constituents of the extracellular matrix 10, also extending existing knowledge on the proteasome of whole bone 18,19. Thus, BCM should reflect
the released activity of various modifications of bone grafts in vitro.
What happens when mesenchymal cells, for example those isolated from bone chips or from oral soft tissue, are exposed to BCM? In vitro, BCM
reduces osteogenic and adipogenic differentiation, and provokes a strong increase of IL11 expression 11. Genome wide microarray revealed
more genes to be differentially expressed in mesenchymal cells in response to BCM. Among these genes are adrenomedullin (ADM), IL11,
IL33, NADPH oxidase 4 (NOX4), proteoglycan 4 (PRG4, or lubricin) and pentraxin 3 (PTX3) 15. BCM obtained from autoclaved bone chips failed
to change the expression of the respective genes 14. BCM from bone chips that underwent pasteurization and freezing was able to change
gene expression 14. Also conditioned medium of demineralized bone matrix (DBM-CM) changes the expression of TGF-β-regulated genes 20.
Interestingly, collagen barrier membranes used to shield the bone chips from the surrounding soft tissue 21,22, adsorbed those parts of BCM that
are responsible for the changes in gene expression 23. BCM research can be extended to other cell types involved in bone regeneration such as
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bone-resorbing osteoclasts and endothelial cells, to name a few. Overall, the accumulating in vitro data provide the scientific basis for the design
of a preclinical study.
The present protocol is two-fold: First, it shows how to prepare BCM. Secondly, it shows how to test its biological activity based on mesenchymal
cells in vitro.
Protocol
1. BCM Preparation
1. Obtain pig mandibles from the local butcher as fresh as possible. Place the mandibles onto a firm surface and release a full thickness flap
paying special attention not to leave any soft tissue or periosteum attached to the bone. Work in a clean environment without the need to
work under the flow hood.
2. Once a full thickness flap is released, use a bone scraper to harvest the bone chips from the buccal side. Please note that the bone scraper
has to be sharp. Handle firmly the bone scraper and with long movements collect the bone. Discard bone chips smaller that 1mm.
1. To maintain native bone chips, place directly the bone chips in plastic dishes of 10cm diameter with Dulbecco's Modified Eagle's
medium (DMEM) supplemented with 1% antibiotics and antimycotics not letting them to dry out.
2. To evaluate the impact of thermal processing, subject bone chips to pasteurization for 30 min at 80 °C or autoclave for 20 min at 121
°C.
3. To evaluate the impact of demineralization, shake bone chips in 1 M HCL for 4-6 hr at 4 °C and wash repeatedly with culture medium
until the pH is neutral.
3. Place a total of 5 g of bone chips per 10 ml fresh DMEM supplemented with 1% antibiotics and antimycotics into a new plastic dish.
4. Place the plastic dishes in a humidified atmosphere at 37 °C for 24 hr. Then, harvest BCM. Centrifuge the BCM at 200 x g for 10 min to
remove debris, filter it sterile (0.2 nm), and keep aliquots frozen at -80 °C.
5. Thaw the BCM stock immediately before use and avoid repeated cycles of freezing and thawing.
6. For indicated experiments, soak collagen membranes with BCM or serum-free medium for 1 hr at RT. Wash vigorously the membranes with
PBS and place them into 96 well plates. Wet membranes are seeded with cells.
7. BCM preparation process is summarized in Figure 1.
2. Bioassays Based on Mesenchymal Cells
1. Seed human mesenchymal cells (for example bone cells, gingival and periodontal ligament fibroblasts) into a 12-well plate with a
concentration of 30,000 cells/cm2. To seed the cells use growth medium consisting of DMEM, 10% fetal calf serum and antibiotics. Let the
cells attach to the plate O/N.
2. Discard the culture medium and wash the cells with pre-warmed PBS at 37 °C. Stimulate the cells by adding pre-warmed serum-free culture
medium with and without 20% BCM. Place the cells in a humidified atmosphere at 37 °C for 24 hr.
3. Discard the culture medium, rinse the cells with pre-warmed PBS and extract the RNA according to your preferred protocol.
4. Adjust the concentration of RNA in order to have the same amount of RNA in each sample. Prepare cDNAs and perform a qRT-PCR to
analyse the selected genes using the primers shown in Table 1.
 
NOTE: These are the dilutions of every component: 2x SYBR Green, 20x primer forward, 20x primer reverse, 5x sterile DD water, 5x cDNA.
The qRT-PCR is performed in 40 cycles of 95 °C 15 sec and 60 °C 1 min.
5. Calculate the relative expression levels by normalizing to the housekeeping gene GAPDH using the Δ(ΔCt) method where ΔCT is CT target -
CT GAPDH and Δ(ΔCT) is ΔCT stimulated - ΔCT control.
6. After this quality control, add BCM to culture medium to stimulate all types of cells including mesenchymal cells, hematopoietic cells or
endothelial cells.
Representative Results
Bone Conditioned Medium is prepared from fresh porcine bone chips. General overview of the process to prepare BCM and to use biomaterials
in combination with BCM is shown in Figure 1 and Figure 2 respectively. During the BCM preparation, it is important to obtain large bone chips
with long movements as short movements or very small bone chips can affect the quality of the final BCM. Quality of BCM can be controlled by
analyzing the gene expression of BCM target genes: ADM, PTX3, IL11, IL33, NOX4 and PRG4 (Figure 3). ADM and PTX3 are down-regulated
down to 0.4-fold and IL11, IL33, NOX4 and PRG4 can be up-regulated to 200-fold. If oral fibroblasts do not express BCM target genes at the
level shown, check the health of the cells or prepare new BCM from new mandibles. Figure 4 displays typical results from the expression of
BCM target genes in oral fibroblasts seeded onto a collagen barrier membrane. Oral fibroblasts stimulated with 20% of conditioned medium from
pasteurized bone chips and conditioned medium from demineralized bone chips, showed similar gene expression to cells stimulated with BCM
(Table 2 and Table 3). However, gene expression of oral fibroblasts exposed to conditioned medium from sterilized (121 °C) bone chips, was
comparable to un-stimulated controls.
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Figure 1. Summary of the process used to prepare bone-conditioned medium from fresh pig mandibles. Please click here to view a larger
version of this figure.
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Figure 2. Summary of the bioassays based on mesenchymal cells with BCM. Please click here to view a larger version of this figure.
 
Figure 3. Gene expression of bone-conditioned medium target genes in oral fibroblasts. Typical results of six genes used to control
the quality of BCM. Genes ADM and PTX3 are downregulated (A) and IL11, IL33, NOX4, PRG4 are upregulated (B). Please click here to view
a larger version of this figure.
 
Figure 4. Gene expression of bone-conditioned medium target genes in oral fibroblasts seeded onto a collagen barrier membrane.
Typical results of six genes used to control the quality of BCM. Genes ADM and PTX3 are downregulated (A) and IL11, NOX4, PRG4 are
upregulated (B). Depending on the biomaterial used, the absorption of growth factors can differ. Collagen membranes failed to absorb factors
that control IL33 expression, therefore IL33 expression is not regulated in this setting. Please click here to view a larger version of this figure.
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Abbreviation Primer forward Primer reverse
GAPDH AGCCACATCGCTCAGACAC GCCCAATACGACCAAATCC
ADM GGACATGAAGGGTGCCTCTC TGTTCATGCTCTGGCGGTAG
IL11 TGCACCTGACACTTGACTGG AGTCTTCAGCAGCAGCAGTC
IL33 TCAGGTGACGGTGTTGATGG GGAGCTCCACAGAGTGTTCC
NOX4 TCTTGGCTTACCTCCGAGGA CTCCTGGTTCTCCTGCTTGG
PRG4  CGACGCCCAATGTAAGAAGT GGTGATGTGGGATTATGCACT
PTX3 TGTATGTGAATTTGGACAACGAA CATTCCGAGTGCTCCTGAC
Table 1: Primer sequence of the 6 genes used.
Genes 80 °C Mean ± SD 121 °C Mean ± SD
ADM 0.2 ± 0.1 1.1 ± 0.2
PTX3 0.1 ± 0.1 0.9 ± 0.2
IL11 20 ± 10 1.5 ± 1
IL33 15 ± 5 1.2 ±  4
NOX4 35 ± 15 2 ± 1
PRG4  40 ± 10 1.8 ± 1
Table 2: Typical gene expression of ADM, PTX3, IL11, IL33, NOX4 and PRG4 in oral fibroblasts stimulated with 20% of conditioned
medium from heat-treated bone chips.
Genes Mean ± SD
ADM 0.1 ± 0.1
PTX3 0.1 ± 0.1
IL11 15 ± 5
IL33 20 ± 10
NOX4 60 ± 15
PRG4 50± 20
Table 3: Typical gene expression of ADM, PTX3, IL11, IL33, NOX4 and PRG4 in oral fibroblasts stimulated with 20% of conditioned
medium from demineralized bone chips.
Discussion
Bone-conditioned medium reflects the released activity of bone grafts during the early stages of bone regeneration. The protocol described here
can be adapted to study the response of different types of cells involved in bone regeneration. Furthermore, the protocol can be used to prepare
conditioned medium from processed bone or bone fillers. The methods are easy to perform and rely on a simple concept: the factors released
from various native and processed bone. Understanding how BCM affects mesenchymal cells can help to learn more about graft consolidation
and properties of bone autografts. Based on this concept we have accumulated knowledge on the impact of BCM obtained from native 11,15
and processed bone 14,20 on gene expression of mesenchymal cells, but also on proliferation, migration, and differentiation into the three main
lineages; osteoblasts, adipocytes and chondrocytes 11. BCM was also examined for its capacity to target hematopoietic cells, for example with
respect to the modulation of osteoclastogenesis 13. Many potential target cells are waiting to respond to BCM in vitro, the protocols presented
here, can serve as a primer for this research.
The presented protocols should also animate to further reveal the molecular mechanisms of how BCM activates particularly TGF-β-regulated
genes in mesenchymal cells. For example, the TGF-β receptor I antagonist SB431542 blocked the effect of BCM on the expression of the gene
panel ADM, IL-11, NOX4, PRG4, and PTX3 11,15. Interestingly, alkaline phosphatase and IL33 were not reversed by SB431542 11,15 suggesting
that other as yet unknown pathways are regulated by BCM. Another open question is what are the molecules in BCM being responsible for the
cellular response? BCM contains TGF-β but is does not explain the complex cellular reactions 10,11. Besides the in vitro cellular aspects, the
overall question remains: to which extend does the released activity of bone grafts as reflected by BCM, have an impact on the in vivo process of
bone regeneration? The protocols and data from bioassays should introduce research in this direction.
This protocol has limitations. BCM cannot be fully standardized because of variations between donors and harvesting techniques. Moreover,
how enzymes present in vivo can affect the composition or activity of BCM remains unknown. Future studies should, for example, focus on how
harvesting techniques affect the “biological activity” of BCM. The role of osteocytes on the composition of BCM should also be studied in detail.
BCM contains sclerostin, a molecule released almost exclusively by osteocytes 12. Limitations, however, provide the inspiration for the next steps
in research. Even though the clinical relevance of research with BCM remains hypothetical, our protocols support the long-standing concept that
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bone grafts, either native or after processing, release a “biological activity”. Understanding how BCM affect cells in vitro can presumably help to
understand how bone autografts will work in vivo.
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